1/9
06:10 am
beam
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at UBS Group AG to a "hold" rating.
Medium
Report
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at UBS Group AG to a "hold" rating.
1/7
03:16 pm
beam
Rating for BEAM
Low
Report
Rating for BEAM
1/7
08:18 am
beam
Beam Therapeutics initiated with a Neutral at UBS
Low
Report
Beam Therapeutics initiated with a Neutral at UBS
1/7
03:00 am
beam
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at UBS Group AG. They set a "neutral" rating on the stock.
Medium
Report
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at UBS Group AG. They set a "neutral" rating on the stock.
11/26
06:43 am
beam
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
11/26
06:43 am
beam
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
11/24
09:55 am
beam
Rating for BEAM
Low
Report
Rating for BEAM
11/24
09:07 am
beam
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Medium
Report
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
11/24
09:07 am
beam
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Medium
Report
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
11/24
08:11 am
beam
Beam Therapeutics initiated with an Outperform at Evercore ISI
Medium
Report
Beam Therapeutics initiated with an Outperform at Evercore ISI
11/24
08:11 am
beam
Beam Therapeutics initiated with an Outperform at Evercore ISI
Medium
Report
Beam Therapeutics initiated with an Outperform at Evercore ISI
11/17
11:03 am
beam
Beam Therapeutics (NASDAQ:BEAM) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
Low
Report
Beam Therapeutics (NASDAQ:BEAM) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
11/17
11:03 am
beam
Beam Therapeutics (NASDAQ:BEAM) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
Low
Report
Beam Therapeutics (NASDAQ:BEAM) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..